FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC

NCT06403111 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

COMBINATION_PRODUCT: Fecal Microbiota Transplantation (FMT)+chemotherapy+immunotherapy

Sponsor

Changzhou No.2 People's Hospital